doi: 10.1016/j.cell.2011.10.033
1407-C COMPARABLE RISK OF RENAL DYSFUNCTION BETWEEN ENTECAVIR AND TENOFOVIR ALAFENAMIDE IN PATIENTS WITH CHRONIC HEPATITIS B Jiwon Yang 1 , Yeojin Lee 1 , Hyeyeon Hong 1 , Sung Won Chung 1 , Minjoo Cho 1 , Won-Mook Choi 2 , Danbi Lee 1 , Ju Hyun Shim 3 , Kang Mo Kim 3 , Young-Suk Lim 4 , Han Chu Lee 1 and Jonggi Choi 3 , (1)Asan Medical Center, Seoul, Korea, Republic of (South), (2)Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea, Seoul, South Korea, (3)Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea, (4)Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South) Background: A previous study suggested a higher higher risk of renal function decline with entecavir (ETV) compared to tenofovir alafenamide (TAF) in treatment-nave patients with chronic hepatitis B (CHB)
Glutathione is crucial for immune function, controlling inflammation, detoxification, skin health, cellular health, energy production and more
Your cart is empty Explore All BundlesExplore All Products LipoCap Glutathione delivers the body's master antioxidant in a premium, bioavailable liposomal capsule - supporting healthy liver function, immune system function and free-radical defence at the cellular level
Factors affecting blood pressure during heavy weight lifting and static contractions
This hypothesis is further supported by clinical observations that more than 60% of accumulated fatty acids in the liver are derived from the circulation in NAFLD patients 7,8
